Corona Remedies Ltd is a domestic pharmaceutical company focused on prescription-based branded generics across acute and chronic therapies. Its revenue comes primarily from manufacturing and marketing formulations in cardiovascular, diabetes, gastro, pain management, and dermatology segments. Its products are used by healthcare providers for treating common and lifestyle-related diseases.

Corona Remedies, an Book Built Issue, amounting to â‚¹655.37 Crore,consisting entirely an offer for sale issue of 0.62 crore shares of ₹655.37 Crore.The subscription period for the Corona Remedies IPO opens on December 08, 2025, and closes on December 10, 2025. The allotment is expected to be finalized on or about Thursday, December 11, 2025., and the shares will be listed on the BSE SME with a tentative listing date set on or about Monday, December 15, 2025.

The Share Price Band of Corona Remedies IPO is set at â‚¹1008 to ₹1062 per equity share. The Market Capitalisation of the Corona Remedies at IPO price of ₹1062 per equity share will be â‚¹ 6495.20 Crores. The lot size of the IPO is 14 shares. Retail investors are required to invest a minimum of  â‚¹ 14,868, 1 lots ( 14 shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots ( 196 shares), amounting to â‚¹ 208,152.

JM Financial Limited, IIFL Capital Services Limited, and Kotak Mahindra Capital Company Limited,are the book running lead manager of the Corona Remedies Limitedwhile Bigshare Services Private Limited. is the registrar for the issue. 

Corona Remedies Limited IPO GMP Today
The Grey Market Premium of Corona Remedies IPO is expected to be â‚¹178 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Corona Remedies Limited IPO Live Subscription Status Today: Real-Time Update
As of 10:30 AM on 09 December, 2025, the Corona Remedies IPO live subscription status shows that the IPO subscribed 6.14 times on its Second Day of subscription period. Check the Corona Remedies IPO Live Subscription Status Today at BSE.

Corona Remedies Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Corona Remedies IPO allotment date is 11 December 2025, Thursday, Corona Remedies IPO Allotment will be out on 11 December 2025, Thursday.and will be live on Registrar Website from the allotment date.
Check Bigshare Services Private Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Corona Remedies IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Corona Remedies Limited IPO
Corona Remedies to utilise the Net Proceeds towards the following objects:Complete issue is Offer For Sale. Therefore, complete IPO proceeds will be transferred to the promoters or the sellers

Refer to Corona Remedies Limited RHP for more details about the Company.